Levitee Labs Inc. announced a non-brokered private placement of up to 15,000,000 units at a price of CAD 0.2 per unit for gross proceeds of up to CAD 3,000,000 on January 18, 2022. Each unit consists of one common share and one common share purchase warrant. Each warrant can be exercised to acquire one common share at a price of CAD 0.4 per share for a period of two years from the date of closing.

The securities are being subject to four months and one day hold period. The company will pay a finder's fee of 8% on the gross proceeds of the transaction from subscribers introduced by certain finders, and will issue finder's warrants equal to 8% of the units sold to subscribers introduced by certain finders. Each finder's warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.4 per finder's warrant for a period of twenty-four months from the date of issuance.